Alvotech CCO Anil Okay steps down to become Adalvo CEO

* Alvotech (NASDAQ:ALVO [https://seekingalpha.com/symbol/ALVO]) on Wednesday announced [https://seekingalpha.com/pr/20274767-alvotech-announces-changes-in-global-business-development-and-commercial-operations-team]changes to its global business development and commercial operations team.
* Anil Okay, Chief Commercial Officer, is stepping down to serve as Chief Executive Officer of Adalvo.
* Trisha Durant has joined Alvotech as Senior Vice President, Global Business Development and Commercial Operations, ex-North America.
* Harshika Sarbajna is Senior Vice President, Commercial, North America. Agne Pasko is Vice President and Head of Business Development.

MORE ON ALVOTECH

* Alvotech: Promising Vertically Integrated Biosimilar Platform [https://seekingalpha.com/article/4830011-alvotech-promising-vertically-integrated-biosimilar-platform]
* Alvotech (ALVO) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript [https://seekingalpha.com/article/4821612-alvotech-alvo-presents-at-morgan-stanley-23rd-annual-global-healthcare-conference-transcript]
* Alvotech 2025 Q2 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4813678-alvotech-2025-q2-results-earnings-call-presentation]
* Alvotech gets marketing approval in Japan for three new biosimilars [https://seekingalpha.com/news/4496521-alvotech-gets-marketing-approval-in-japan-for-three-new-biosimilars]
* Alvotech, Advanz Pharma get EU nod for Eylea biosimilar [https://seekingalpha.com/news/4487943-alvotech-advanz-pharma-get-eu-nod-for-eylea-biosimilar]